Dose-Adjusted Revlimid-Dexamethasone Combination Is Safe And Effective In ...
The Myeloma Beacon
Approximately 20 percent of multiple myeloma patients develop kidney failure, and in 2009, the US Food and Drug Administration (FDA) announced a revision to ...



Lexington Herald Leader

Expert on multiple myeloma to speak at UK Friday
Lexington Herald Leader
Multiple myeloma is a rare blood disease that is generally considered incurable, although remissions can occur with treatment. Richardson will be holding ...



Unlocking Cancer Drug Mechanism May Avoid Risk of Birth Defects
BusinessWeek
s Revlimid and Thalomid, multiple myeloma medicines, are derived from thalidomide. The finding, in a study using zebrafish and chicks, may help expand the ...



BBC News

Researchers Gain New Insights into the Mystery of Thalidomide-Caused Birth Defects
Scientific American
In the 1990s the US Food and Drug Administration approved its use in the treatment of both multiple myeloma (a form of cancer that affects plasma cells) and ...
Thalidomide's Partner in CrimeScience Now
Identification of a Primary Target of Thalidomide TeratogenicityScience Magazine (subscription)

all 11 news articles »


Oran woman inspired by teen shaves head for cancer
KFVS
Helen Savata, 39, was diagnosed with multiple myeloma six years ago. She says she was inspired to shave her head after watching a story on Heartland News ...



New cancer support group to provide information about myeloma
Shreveport Times
LaRocque scoured the Internet and books for information on myeloma, a cancer of the bone marrow, ...

and more »


Myeloma Support Group
WEAU-TV 13
This support group is intended for patients, caregivers and family members involved with or interested in multiple myeloma. ...
Caregiver Support Group to meet Wed., March 10Wayne Independent

all 2 news articles »


Beacon NewsFlashes – March 9, 2010
The Myeloma Beacon
Perifosine Receives “Orphan Medicinal Product Designation” In Europe For Myeloma – On March 1, Aeterna Zentaris announced that it received a positive ...



Regardless Of Prior Therapies, Velcade Is Superior Over Dexamethasone In ...
The Myeloma Beacon
Exposure to prior myeloma therapies, specifically thalidomide (Thalomid) and autologous stem cell transplants (ASCT), does not influence the superior ...



ModernMedicine

Focal Lesions Found to Predict Multiple Myeloma Progression Related study ...
ModernMedicine
In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age. Heinz Ludwig, MD, from the ...


Google News